Correlation Between Enzymatica Publ and Moberg Pharma
Can any of the company-specific risk be diversified away by investing in both Enzymatica Publ and Moberg Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzymatica Publ and Moberg Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzymatica publ AB and Moberg Pharma AB, you can compare the effects of market volatilities on Enzymatica Publ and Moberg Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzymatica Publ with a short position of Moberg Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzymatica Publ and Moberg Pharma.
Diversification Opportunities for Enzymatica Publ and Moberg Pharma
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Enzymatica and Moberg is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Enzymatica publ AB and Moberg Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moberg Pharma AB and Enzymatica Publ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzymatica publ AB are associated (or correlated) with Moberg Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moberg Pharma AB has no effect on the direction of Enzymatica Publ i.e., Enzymatica Publ and Moberg Pharma go up and down completely randomly.
Pair Corralation between Enzymatica Publ and Moberg Pharma
Assuming the 90 days trading horizon Enzymatica Publ is expected to generate 66.45 times less return on investment than Moberg Pharma. But when comparing it to its historical volatility, Enzymatica publ AB is 1.87 times less risky than Moberg Pharma. It trades about 0.01 of its potential returns per unit of risk. Moberg Pharma AB is currently generating about 0.45 of returns per unit of risk over similar time horizon. If you would invest 1,117 in Moberg Pharma AB on August 25, 2024 and sell it today you would earn a total of 709.00 from holding Moberg Pharma AB or generate 63.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enzymatica publ AB vs. Moberg Pharma AB
Performance |
| Timeline |
| Enzymatica publ AB |
| Moberg Pharma AB |
Enzymatica Publ and Moberg Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enzymatica Publ and Moberg Pharma
The main advantage of trading using opposite Enzymatica Publ and Moberg Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzymatica Publ position performs unexpectedly, Moberg Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moberg Pharma will offset losses from the drop in Moberg Pharma's long position.The idea behind Enzymatica publ AB and Moberg Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Moberg Pharma vs. Swedencare publ AB | Moberg Pharma vs. Enzymatica publ AB | Moberg Pharma vs. KABE Group AB | Moberg Pharma vs. IAR Systems Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |